Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort
Authors:
- O. RascolORO. Rascol
- for the COPARK Study GroupFGfor the COPARK Study Group
- 1 April 2011
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 19 (1) , 28-37
Abstract
Introduction: Abnormal oro‐buccal functions including dysarthria, sialorrhea and dysphagia commonly affect patients with Parkinson’s disease (PD).Objectives: To estimate the prevalence of such oro‐buccal symptoms at baseline in the first 419 patients with PD included in the COPARK cohort and to analyze their correlations with patients’ demographics, clinical characteristics, and drugs consumption.Methods: Patients were assessed using the Unified PD Rating Scale, the Hospital Anxiety and Depression Scale, and the PDQ‐39. Dysarthria, sialorrhea, and dysphagia were defined as UPDRS items 5, 6, or 7 ≥ 1.Results: Dysarthria, sialorrhea, or dysphagia were present in 51%, 37%, or 18% out of the 419 patients, respectively. At least one of these symptom was present in 267/419 patients (65%), whilst a combination of symptoms was present in 136/419 (33%). Logistic regression showed that the presence of each of the three oro‐buccal symptoms was significantly correlated with that of the two others. Other correlations included male gender, hallucinations, disease severity, levodopa use and lack of opiates consumption for dysarthria; disease severity, orthostatic hypotension and absence of antidepressants consumption for sialorrhea; female gender, motor fluctuations, and depressive symptoms for dysphagia. None of the three oro‐buccal symptoms were associated with a reduced PDQ‐39 score.Conclusion: Oro‐buccal symptoms were present in two of three patients with moderate PD, the presence of each symptoms being significantly correlated with that of the two others.Keywords
This publication has 41 references indexed in Scilit:
- Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP studyMovement Disorders, 2010
- Effects of Dopamine D1and D2Receptor Antagonists on Laryngeal Neurophysiology in the RatJournal of Neurophysiology, 2009
- The relationship between quality of life and swallowing in Parkinson's diseaseMovement Disorders, 2009
- Quantitation of non‐motor symptoms in Parkinson’s diseaseEuropean Journal of Neurology, 2008
- Chronic pain in Parkinson's disease: The cross‐sectional French DoPaMiP surveyMovement Disorders, 2008
- For better or worse: The effect of levodopa on speech in Parkinson's diseaseMovement Disorders, 2007
- The Coordination of Breathing and Swallowing in Parkinson’s DiseaseDysphagia, 2007
- Prevalence and pattern of perceived intelligibility changes in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2007
- A Pilot Study of Respiration and Swallowing Integration in Parkinson’s Disease: “On” and “Off” LevodopaDysphagia, 2007
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995